03/06/2025
๐๐ก๐ซ๐จ๐ง๐ข๐ ๐ฉ๐๐ข๐ง ๐ข๐ฆ๐ฉ๐๐๐ญ๐ฌ ๐๐ฉ๐ฉ๐ซ๐จ๐ฑ๐ข๐ฆ๐๐ญ๐๐ฅ๐ฒ ๐ ๐ข๐ง ๐ ๐ข๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐๐ฅ๐ฌ, highlighting the urgent need opioid-free pain relief alternatives.
Scientific advancements in pain research have highlighted the identification of analgesic ion channel and transporter targets that could redefine pain medications. Aurora Biomed was the first to develop a non-radioactive, label-free technology for the study and high throughput screening of ion channel and transporter targets, and ever since it has granted a more thorough understanding of relevant pain targets, such as ๐๐๐, ๐ก๐๐๐, ๐๐๐ฏ๐.๐, ๐๐๐๐ ๐๐ง๐ ๐๐๐๐๐.
Ion Channel Readers (ICRs) are essential for advancing this research, aiding scientists in studying and developing safer medications for pain drug targets.
Learn more about this technology here or email us at [email protected] for more information:https://www.aurorabiomed.com/wp-content/uploads/2024/10/Aurora-Brochure-Ion-Channel-Readers.pdf
.7
Reference: International Association for the Study of Pain (IASP). (2023). High-impact chronic pain [Fact sheet]. Retrieved from https://www.iasp-pain.org/resources/fact-sheets/high-impact-chronic-pain/